Crossmark

Mycobacterium tuberculosis whole genome sequencing provides insights into the Manila strain and drug-resistance mutations in the Philippines

Crossref DOI link: https://doi.org/10.1038/s41598-019-45566-5

Published Online: 2019-06-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Phelan, Jody E. https://orcid.org/0000-0001-8323-7019
Lim, Dodge R. https://orcid.org/0000-0002-6271-3861
Mitarai, Satoshi

de Sessions, Paola Florez

Tujan, Ma. Angelica A. https://orcid.org/0000-0002-4169-2731
Reyes, Lorenzo T.

Medado, Inez Andrea P.

Palparan, Alma G.

Naim, Ahmad Nazri Mohamed

Jie, Song

Segubre-Mercado, Edelwisa

Simoes, Beatriz

Campino, Susana

Hafalla, Julius C.

Murase, Yoshiro

Morishige, Yuta https://orcid.org/0000-0002-3818-5288
Hibberd, Martin L.

Kato, Seiya

Ama, Ma. Cecilia G.

Clark, Taane G. https://orcid.org/0000-0001-8985-9265
Funding

Funding for this research was provided by:

Newton Fund (British Council. 261868591)

Japan Agency for Medical Research and Development (JP16fk0108204)

Japan Agency for Medical Research and Development (JP16fk0108204)

Japan Agency for Medical Research and Development (JP16fk0108204)

Japan Agency for Medical Research and Development (JP16fk0108204)

RCUK | Medical Research Council (MR/R025576/1)

RCUK | Medical Research Council (MR/R020973/1)

RCUK | Medical Research Council (MR/M01360X/1)

RCUK | Medical Research Council (MR/N010469/1)

RCUK | Medical Research Council (MR/R025576/1)

RCUK | Medical Research Council (MR/R020973/1)

RCUK | Biotechnology and Biological Sciences Research Council (BB/R013063/1)
License Information

Text and Data Mining valid from 2019-06-26

Version of Record valid from 2019-06-26
More Information

Article History

Received: 22 April 2019

Accepted: 10 June 2019

First Online: 26 June 2019

Competing Interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below